Survivorship, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.

Denlinger CS, Sanft T, Baker KS, Broderick G, Demark-Wahnefried W, Friedman DL, Goldman M, Hudson M, Khakpour N, King A, Koura D, Lally RM, Langbaum TS, McDonough AL, Melisko M, Montoya JG, Mooney K, Moslehi JJ, O'Connor T, Overholser L, Paskett ED, Peppercorn J, Pirl W, Rodriguez MA, Ruddy KJ, Silverman P, Smith S, Syrjala KL, Tevaarwerk A, Urba SG, Wakabayashi MT, Zee P, McMillian NR, Freedman-Cass DA
J Natl Compr Canc Netw. 2018 16 (10): 1216-1247

PMID: 30323092 · PMCID: PMC6438378 · DOI:10.6004/jnccn.2018.0078

MeSH Terms (18)

Anthracyclines Antibiotics, Antineoplastic Antineoplastic Agents, Immunological Bacterial Infections Cancer Survivors Cardiotoxicity Humans Immunocompromised Host Lymphedema Mass Screening Medical Oncology Neoplasms Risk Assessment Societies, Medical Survivorship United States Vaccination Virus Diseases

Connections (1)

This publication is referenced by other Labnodes entities:

Links